… PD-1 pathway inhibition in combination were overall well tolerated in the study population.
No … were observed between PD-1 pathway inhibitor-naive and PD-1 inhibitor-treated patients. …

… on combining checkpoint … PD-1 inhibition combined with irradiation led to fewer tumor-infiltrating
myeloid-derived suppressor cells in the lesion's microenvironment and that anti-PD-1 …

… radiation therapy combined with immunotherapy or targeted … renal cell carcinoma ceased
using cabozantinib—a multi-target inhibitor of angiogenesis, C-MET, RET, and other pathways…

… (IMRT), stereotactic body radiation therapy, and stereotactic radiosurgery are sophisticated
… of combining radiotherapy with simultaneous inhibition of the CTLA-4 and PD-L1 pathways. …

… PD-1 and PD-L1 signalling pathway … safety concerns, there is an urgent need to
comprehensively understand the toxicity profiles of PD-1 or PD-L1 inhibitor-based combination …

… The NIVES trail has only observed an ORR of 19% in patients receiving nivolumab plus …
on the safety and efficacy of combining SBRT with non-first-line PD-1 inhibitors and targeted …

… from preclinical data and summarizing safety data from relevant … trials combining RT and
PD-1/PD-L1 inhibitors (Table 1) … from the combination of radiation therapy with immunotherapy …

… low response rate of α-PD-1/PD-L1 therapy remains to be resolved. For most cancer patients,
PD-1/PD-L1 pathway is not … , radiotherapy, angiogenesis inhibitors, targeted therapy, other …

… can overcome the upregulated inhibitory pathways and molecules triggered by RT, thereby
… and safety of anti-PD1/PDL1 combined with RT and anti-angiogenic agents in the treatment …

… body radiation therapy (SBRT), as a novel radiotherapy modality … could block the negative
regulatory pathway, which further … safety of the combination remains to be further investigated. …